These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22166275)

  • 81. [Use of a mathematical model to establish normal serum parameters characterizing the function of the fetoplacental complex].
    Shmagel' KV
    Klin Lab Diagn; 1995; (3):28-32. PubMed ID: 8689051
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prenatal Biochemical Screening and a Woman's Long-Term Risk of Cancer: A Population-Based Cohort Study.
    Park AL; Huang T; Meschino WS; Iqbal J; Ray JG
    JNCI Cancer Spectr; 2020 Feb; 4(1):pkz077. PubMed ID: 32110774
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Variability of adjustments to indices in determining patient risk in biochemical screening.
    Brooks K; Chik L; O'Brien JE; Ayoub M; Johnson MP; Evans MI
    Fetal Diagn Ther; 1999; 14(1):41-6. PubMed ID: 10072650
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inhibition of lymphocyte transformation by serum from pregnant women: lack of correlation with levels of alpha-fetoprotein.
    Papiha SS; Wajner M; Wagstaff TI
    Biol Neonate; 1983; 43(3-4):109-17. PubMed ID: 6190515
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of liver and renal dysfunction on circulating methionine-enkephalin immunoreactivity.
    Smith R; Grossman A; Gimson AE; Besser GM; Rees LH
    Neurosci Lett; 1985 Oct; 60(3):301-5. PubMed ID: 4069438
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Biochemical Assessment of Renal and Liver Function among Preeclamptics in Lagos Metropolis.
    Ekun OA; Olawumi OM; Makwe CC; Ogidi NO
    Int J Reprod Med; 2018; 2018():1594182. PubMed ID: 30155474
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Interaction of polystyrene microspheres with liver cells: roles of membrane receptors and serum proteins.
    Ogawara K; Yoshida M; Takakura Y; Hashida M; Higaki K; Kimura T
    Biochim Biophys Acta; 1999 Oct; 1472(1-2):165-72. PubMed ID: 10572937
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of Preanalytical Factors on the Stability of Maternal Serum Biomarkers and Calculated Risk for Trisomy 21, Trisomy 18, and Open Neural Tube Defect.
    Walker BS; Barakauskas VE; Grenache DG; Schmidt RL
    J Appl Lab Med; 2017 May; 1(6):690-701. PubMed ID: 33379822
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practice.
    Njei B; Lim JK
    Aliment Pharmacol Ther; 2024 Jul; 60(1):83-84. PubMed ID: 38643498
    [No Abstract]   [Full Text] [Related]  

  • 90. Care is needed when using serum sodium levels to predict survival for patients with advanced liver disease.
    Jones BJ; Twomey PJ
    Gut; 2007 Dec; 56(12):1799-800. PubMed ID: 17998330
    [No Abstract]   [Full Text] [Related]  

  • 91. Elevated human chorionic gonadotropin levels in patients with chronic kidney disease: Case series and review of literature.
    Soni S; Menon MC; Bhaskaran M; Jhaveri KD; Molmenti E; Muoio V
    Indian J Nephrol; 2013 Nov; 23(6):424-7. PubMed ID: 24339520
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Maternal serum triple analyte screening in pregnancy.
    Graves JC; Miller KE; Sellers AD
    Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures.
    Ying I; Wyatt PR; Nisenbaum R; Ray JG
    J Obstet Gynaecol Can; 2011 Dec; 33(12):1218-1222. PubMed ID: 22166275
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Maternal serum screening in Ontario using the triple marker test.
    Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
    J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.